T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFLY
1351
DELISTED
Shutterfly, Inc.
SFLY
| $9.41M | ﹤0.01% |
196,800
+25,900
| +15% | +$1.2M |
|
|
NAME
1352
DELISTED
Rightside Group, Ltd.
NAME
| $9.34M | ﹤0.01% |
1,378,850
+279,360
| +25% | +$2.35M |
|
1353
Ulta Beauty
ULTA
$22.2B
| $9.32M | ﹤0.01% |
60,371
+2,220
| +4% | +$341K |
|
1354
Warner Bros
WBD
$69.6B
| $9.29M | ﹤0.01% |
279,430
+40,900
| +17% | +$1.35M |
|
1355
TSMC
TSM
$2.23T
| $9.29M | ﹤0.01% |
409,018
+356,450
| +678% | +$8.51M |
|
|
CWEN.A
1356
DELISTED
Clearway Energy Class A
CWEN.A
| $9.26M | ﹤0.01% |
+421,140
| New | +$10.3M |
|
1357
Clearway Energy Class C
CWEN
$7.02B
| $9.22M | ﹤0.01% |
421,240
-424,840
| -50% | -$10.7M |
|
|
INVX
1358
Innovex International
INVX
$2.15B
| $9.2M | ﹤0.01% |
122,300
+800
| +0.7% | +$60.2K |
|
|
GRMN
1359
Garmin
GRMN
$60.2B
| $9.18M | ﹤0.01% |
208,990
+2,400
| +1% | +$111K |
|
1360
Toll Brothers
TOL
$14B
| $9.15M | ﹤0.01% |
239,620
+4,640
| +2% | +$174K |
|
|
JPM.WS
1361
DELISTED
JPMorgan Chase
JPM.WS
| $9.14M | ﹤0.01% |
369,300
| – | – |
|
|
QVCGA
1362
DELISTED
QVC Group Inc Series A
QVCGA
| $9.12M | ﹤0.01% |
6,771
+175
| +3% | +$243K |
|
1363
Dick's Sporting Goods
DKS
$18.1B
| $9.11M | ﹤0.01% |
175,981
+4,585
| +3% | +$252K |
|
|
ESL
1364
DELISTED
Esterline Technologies
ESL
| $9M | ﹤0.01% |
94,390
+2,900
| +3% | +$310K |
|
1365
Pegasystems
PEGA
$5.51B
| $8.96M | ﹤0.01% |
782,400
+2,400
| +0.3% | +$26.5K |
|
1366
Advanced Micro Devices
AMD
$789B
| $8.95M | ﹤0.01% |
3,729,535
+3,522,863
| +1,705% | +$8.53M |
|
|
WLH
1367
DELISTED
WILLIAM LYON HOMES
WLH
| $8.9M | ﹤0.01% |
346,600
+6,800
| +2% | +$160K |
|
1368
Teradata
TDC
$2.57B
| $8.89M | ﹤0.01% |
240,161
+2,800
| +1% | +$115K |
|
|
ONIT
1369
Onity Group
ONIT
$330M
| $8.88M | ﹤0.01% |
58,070
+55,940
| +2,626% | +$8.14M |
|
|
PBCT
1370
DELISTED
People's United Financial Inc
PBCT
| $8.86M | ﹤0.01% |
546,427
+6,200
| +1% | +$96.3K |
|
1371
Assurant
AIZ
$13.9B
| $8.85M | ﹤0.01% |
132,045
| – | – |
|
1372
Howard Hughes
HHH
$4.04B
| $8.77M | ﹤0.01% |
64,120
| – | – |
|
1373
Carlyle Group
CG
$18.3B
| $8.74M | ﹤0.01% |
310,500
+75,900
| +32% | +$2.22M |
|
|
BOJA
1374
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $8.71M | ﹤0.01% |
+365,200
| New | +$9.22M |
|
1375
GameStop
GME
$8.33B
| $8.63M | ﹤0.01% |
803,400
+138,360
| +21% | +$1.42M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.